Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical’s Proposed Sale to Alcon Inc.
Expresses Disappointment in the Board's and Management's Continued Pursuit of Ill-advised Deal Defender Capital (“Defender” or “we”), a long-term shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement reiterating its intention to vote AGAINST the Company's proposed sale to Alcon […]